Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Advanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

ACTA VETERINARIA HUNGARICA is a prestigious academic journal published by AKADEMIAI KIADO ZRT, dedicated to the diverse field of veterinary science. With a history spanning over three decades since its inception in 1983, this journal provides a platform for the dissemination of high-quality research, clinical studies, and reviews that contribute to advancing knowledge in veterinary medicine and animal health. Based in Hungary, it has built a respectable reputation, reflected in its Scopus ranking, where it occupies the 84th position out of 194 in the General Veterinary category, placing it within the 56th percentile. Although the journal is not open access, it continues to attract a global audience of researchers, professionals, and students who are keen on exploring advancements in veterinary science as it converges towards its upcoming year of 2024. Readers will find valuable insights that foster innovation and improve animal care practices across various settings, making ACTA VETERINARIA HUNGARICA an essential resource for anyone involved in the veterinary field.

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.